By Brendan Pierson (Reuters) - The sprawling, five-year-long litigation over the U.S. opioid crisis appears to be entering its final phase with finali.
/PRNewswire/ Global Migraine Drugs Market 2022-2026 The analyst has been monitoring the migraine drugs market and it is poised to grow by $1 bn during.
/PRNewswire/ The "Bronchiectasis Drugs Market by Product and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio s offering. The.
/PRNewswire/ The "Bronchiectasis Drugs Market by Product and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio s offering. The.
Company completed a public offering for aggregate gross proceeds of $16.8 millionMajority of clinical sites now open in clinical study to evaluate QRX003.